Targeting glycosylated PD-L1 blocks PD-L1/PD-1 interaction and promotes PD-L1 internalization and degradation, resulting in the efficient eradication of 4T1 TNBC tumor growth and elongation of mouse survival [202]. This evidence concerns the gene CD274 and neoplasm.